Case 2 : Management of Uncontrolled Hyperglycemia in a High Risk Diabetic Patient
Real World Case Series Issue 2
Clinical Case Brief
70 Year old Male
Social History :
- Addicted to Tobacco and following sedentary Lifestyle
Family History :
- Mother had T2DM
Physical Examination :
- BP: 120/70 mmHg
- Pulse: 104 beats/min
- Height: 157 cm
- Body Weight: 72.7 Kg
Laboratory Investigations before 13th Dec, 2023
- HbA1c: 7.3%
- FBG: 242 mg/dl
- PPG: 328 mg/dl
- Creatinine: 1.52 mg/dl
Medical History :
- T2DM from last 8 years
- Hypothyroidism from last 14 years Also Diagnosed with following on 3rd Nov’ 23
- Dyslipidemia, Chronic Pancreatic Disease, Diabetic Kidney Disease
- Heart Disease
- Had undergone Cholecystectomy
Medication History :
- Metformin- 1000 mg OD
- Empagliflozin-25 mg OD
- Glimepiride-4 mg OD
- Thyroxine - 75 µg OD
- Rosuvastatin- 10 mg OD
- Etizolam-0.5 mg OD
- Torsemide- 5mg OD
- Silodosin + Dutasteride (8+0.5) mg OD
Patient Diagnosis: Uncontrolled Hyperglycemia
Expert's Concern :
- Patient with Uncontrolled Hyperglycemia especially HbA1c and fasting plasma Glucose in the background of Chronic pancreatic disease
Revised Treatment on 13th Dec’ 2023 with Addition of Imeglimin: 1000 mg B.D.
Replaced Medication
- Empagliflozin and Glimepiride
Post Follow up Changes in Medication :
- Imeglimin: 1000 mg B.D
- Metformin- 500 mg B.D
- Gliclazide-60 mg BD
- Pioglitazone- 15 mg BD
Key Findings after using Imeglimin
- HbA1c: 8.6 %
- FBG: 172 mg/dl
- PPG: 71 mg/dl
Major Highlights of the Case
Changes Done in Medication :
- Replacement of Empagliflozin and Glimepiride with Addition of Imeglimin and Gliclazide Reduced the dose of Pioglitazone from 30mg to 15mg
Follow up Advice :
- Imeglimin: 1000mg B.D continue for next 3 months
Experts’ View :
- The Fasting Plasma Glucose at baseline 242 mg/dl is reduced to 172 mg/ dl
- Post prandial plasma glucose at baseline 328 is reduced to 71 mg/dl in 2 months
- The result of HbA1c will be followed after 3 months in periodic Check up
Benefits to patient :
- No Adverse effect
- No Hypoglycemia